HomeBusinessHealthcareSynaptogenix (SNPX) President On The Fight Against Alzheimer's
Synaptogenix (SNPX) President On The Fight Against Alzheimer's

Synaptogenix (SNPX) is a clinical-stage biopharmaceutical company that works on therapies for neurodegenerative diseases. The Synaptogenix lead therapeutic candidate called Bryostatin-1 is being studied as a treatment for Alzheimer's. "We dive right in to treating the real disease in advanced patients, and we’ve seen improvement, ” says President & Chief Scientific Officer Dr. Daniel Alkon.

ON AIR
education
10:30 pm
Your First Trade
replay
12:00 am
Fast Market
REPLAY
1:00 am
Trading 360
REPLAY
2:00 am
Next Gen Investing
REPLAY
education
3:00 am
Your First Trade
REPLAY
3:30 am
Trading 360
REPLAY
4:30 am
Next Gen Investing
REPLAY
education
5:30 am
Your First Trade
REPLAY
6:00 am
Fast Market
REPLAY
7:00 am
Futures
8:00 am
Morning Trade Live
10:00 am
Trading 360
11:00 am
Fast Market
12:00 pm
Next Gen Investing
1:00 pm
The Watch List
2:00 pm
Market On Close
education
3:30 pm
Your First Trade
4:00 pm
Trading 360
REPLAY
5:00 pm
Fast Market
REPLAY
6:00 pm
Next Gen Investing
REPLAY
education
7:00 pm
Your First Trade
REPLAY
7:30 pm
Trading 360
REPLAY
8:30 pm
Fast Market
REPLAY
9:30 pm
Next Gen Investing
REPLAY
ON AIR
education
10:30 pm
Your First Trade
REPLAY
11:00 pm
Trading 360
REPLAY

Get Market Minute

Daily insights for every investor

FOLLOW US